Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
EBIT Margin (QoQ)EBIT Margin Growth (1y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBT Margin (QoQ)EBT Margin Growth (1y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)FCF Margin (QoQ)FCF Margin Growth (1y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Net Margin (QoQ)Net Margin Growth (1y)Operating Margin (QoQ)Operating Margin Growth (1y)Return on Assets Growth (3y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Equity Growth (3y)Return on Invested Capital (QoQ)Return on Sales (QoQ)Return on Sales Growth (1y)
Income Statement
Others
Ratios

Arcellx (ACLX) Interest Coverage Ratio Growth (1y) (2023 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 15.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -303.06%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 18.06%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.72%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,150.63%
10 Arcellx 6.48 Bn 6.48 Bn - -160.60%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -160.60%
Mar 31, 2025 -21,253.59%
Dec 31, 2024 -49,559.97%
Sep 30, 2024 -530.35%
Jun 30, 2024 -224.53%
Mar 31, 2024 9.42%
Dec 31, 2023 142.83%
Sep 30, 2023 70.30%
Jun 30, 2023 99.68%
Mar 31, 2023 99.54%